Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 28 , ISSUE 11 ( November, 2024 ) > List of Articles

EDITORIAL

Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays

Amol Trimbakrao Kothekar, Keyurkumar B Shah

Keywords : Acute on chronic liver failure, Albumin, Cirrhosis of liver, Cirrhotic cardiomyopathy hepatorenal syndrome, Lung ultrasound score, Point-of-care ultrasound, Radiographic assessment of lung edema score, Terlipressin

Citation Information : Kothekar AT, Shah KB. Echoes and Shadows: Predicting Hepatorenal Syndrome Outcomes with Lung Ultrasound and X-rays. Indian J Crit Care Med 2024; 28 (11):993-994.

DOI: 10.5005/jp-journals-10071-24836

License: CC BY-NC 4.0

Published Online: 30-10-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

HTML PDF Share
  1. Nadim MK, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis. N Engl J Med 2023;388(8):733–745. DOI: 10.1056/NEJMra2215289.
  2. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996;23(1):164–176. DOI: 10.1002/hep.510230122.
  3. Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. J Hepatol 2019;71(4):811–822. DOI: 10.1016/j.jhep.2019.07.002.
  4. Patidar KR, Belcher JM, Regner KR, St Hillien SA, Simonetto DA, Asrani SK, et al. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol 2023;79(6):1408–1417. DOI: 10.1016/j.jhep.2023. 07.010.
  5. Nadim MK, Kellum JA, Forni L, Francoz C, Asrani SK, Ostermann M, et al. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol 2024;81(1):163–183. DOI: 10.1016/j.jhep.2024.03.031.
  6. Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, et al. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med 2021;384(9):818–828. DOI: 10.1056/NEJMoa2008290.
  7. Møller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol 2010;53(1):179–190. DOI: 10.1016/j.jhep.2010.02.023.
  8. Amara V, Kulkarni AV, Gupta A, Venishetty S, Sripathi SR, Reddy LSK, et al. Point-of-care ultrasonography in patients with hepatorenal syndrome: A single center observational study. Indian J Crit Care Med 2024;28(11):1015–1022.
  9. Premkumar M, Kajal K, Reddy KR, Izzy M, Kulkarni AV, Duseja AK, et al. Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography. Hepatology 2024;79(5):1048–1064. DOI: 10.1097/hep.0000000000000691.
  10. Koratala A. Point-of-care ultrasonography in cirrhosis-related acute kidney injury: How I do it. World J Crit Care Med 2024;13(2):93812. DOI: 10.5492/wjccm.v13.i2.93812.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.